{"text_format":"3","workbook":"xls","n_sheets":1,"sheets":["table 1"],"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"table 1","index":0,"n_rows":7,"n_cols":2,"rows_kept":7,"merged":[[0,0,0,1],[6,0,6,1]],"flags":["formulas_cached_only"]}
["Table 1. Conditions of the clinical test and its interpretation in the mathematical model."]
["RATE","CONDITIONS"]
["MIPGU"," The glucose concentration was maintained in its basal state by a glucose clamp (i.e. MIPGU = 1 ). The above allows to observe the isolated effect of insulin in the peripheral glucose uptake (i.e.  MIPGU ) by knowing the normalized value of the peripheral glucose uptake (i.e. rNPGU = rPGU / rBPGU)."]
["MGHGP"," Somatostatin was administered to block the endogenous release of insulin and glucagon. Exogenous insulin and glucagon replacements were introduced to the patients to maintain them in their basal state (i.e. MΓHGP = 1, x21=x*21). The above allows to observe the isolated effect of glucose on the hepatic glucose production (i.e. MGHGP) by knowing the normalized value of hepatic glucose production (i.e. rNHGP = rHGP / rBHGP)"]
["MI∞HGP"," Glucose concentration was maintained at basal state by means of a glucose clamp. The above allows to observe the isolated effect of insulin in the hepatic glucose production  after a stabilization time (i.e. MI∞HGP). "]
["MΓ0HGP"," Somatostatin was administered to block the endogenous release of insulin and glucagon. Exogenous insulin and glucose replacements were introduced to the patients to maintain them in their basal state by means of a glucose clamp  (i.e.  MGHGP = 1, x21 = x*21). The above allows to observe the isolated effect of glucagon on the hepatic glucose production (i.e. MΓ0HGP) by knowing the normalized value of hepatic glucose production (i.e.  rNHGP = rHGP / rBHGP)."]
["The clinical data from the studies that fulfill the criteria in the table were used to fit the isolated effects of the sensitive metabolic rates of the model."]